Registrants (1)
030705628
Manufacturing Establishments (1)
Antigen Laboratories, Inc.
Antigen Laboratories, Inc.
030705628
Products (23)
Guinea Pig Hair
49288-0229
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Goose Feather
49288-0225
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Rabbit Hair
49288-0443
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Feather Mixture
49288-0207
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Goat Hair
49288-0224
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Horse Hair
49288-0257
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Duck Feather
49288-0167
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Canary Feather
49288-0127
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Dog Hair
49288-0164
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Deer Hair
49288-0168
BLA102223
BLA (C73585)
SUBCUTANEOUS, INTRADERMAL
November 20, 2009
Drug Labeling Information
BOXED WARNING SECTION
WARNINGS
ADVERSE REACTIONS SECTION
ADVERSE REACTIONS
Adverse reactions include, but are not limited to urticaria; itching; edema of extremities; respiratory wheezing or asthma; dyspnea; cyanosis; tachycardia; lacrimation; marked perspiration; flushing of face, neck or upper chest; mild persistent clearing of throat; hacking cough or persistent sneezing.
- Local Reactions
A mild burning immediately after injection is expected; this usually subsides in 10-20 seconds. Prolonged pain or pain radiating up arm is usually the result of intramuscular injection, making this injection route undesirable. Subcutaneous injection is the recommended route.
Small amounts of erythema and swelling at the site of injection are common. Reactions should not be considered significant unless they persist for at least 24 hours or exceed 50 mm in diameter.
Larger local reactions are not only uncomfortable, but indicate the possibility of a severe systemic reaction if dosage is increased. In such cases dosage should be reduced to the last level not causing reaction and maintained for two or three treatments before cautiously increasing.
Large, persistent local reactions or minor exacerbations of the patient’s allergic symptoms may be treated by local cold applications and/or use of oral antihistamines.
- Systemic Reactions
Systemic reactions range from mild exaggeration of patient’s allergic symptoms to anaphylactic reactions.14 Very sensitive patients may show a rapid response. It cannot be overemphasized that, under certain unpredictable combinations of circumstances, anaphylactic shock is always a possibility. Fatalities are rare but can occur.5 Other possible systemic reaction symptoms are fainting, pallor, bradycardia, hypotension, angioedema, cough, wheezing, conjunctivitis, rhinitis,and urticaria.13, 14
Careful attention to dosage and administration limit such reactions. Allergenic extracts are highly potent to sensitive individuals and OVERDOSE could result in anaphylactic symptoms. Therefore, it is imperative that physicians administering allergenic extracts understand and prepare for treatment of severe reactions. Refer to “OVERDOSAGE” section.